Research study Program year 2020 Source: CMS Open Payments

An Open Label, Long Term, Safety Study of Lasmiditan 100 MG and 200 MG in the Acute Treatment of Migraine Gladiator

ClinicalTrials.gov NCT03182920

Research payments

$891,628

265 payments

Through program year 2020, $891,628 in research payments was reported against An Open Label, Long Term, Safety Study of Lasmiditan 100 MG and 200 MG in the Acute Treatment of Migraine Gladiator, across 265 payments, paid by Eli Lilly and Company.

Paid by: Eli Lilly and Company
ClinicalTrials.gov: NCT03182920

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$237,253	107
2019	Research	$654,376	158

Breakdown

Who paid Research payments · program years 2019–2020

Eli Lilly and Company $891,628 265 payments

Who received the money Research payments · program years 2019–2020

Pab Clinical Research INC Organisation paid for research $158,862 3 payments
Heartland Research Associates LLC Organisation paid for research $119,101 12 payments
Clinical Research Advantage Organisation paid for research $57,536 21 payments
Teradan Clinical Trials LLC Organisation paid for research $40,637 2 payments
Meridien Research Organisation paid for research $32,334 9 payments
Doctors Clinical Research Organisation paid for research $25,254 3 payments
Visionary Investigators Network Organisation paid for research $24,109 3 payments
Bb Holdings LLC Organisation paid for research $22,270 2 payments
Pharmacology Research Institute Organisation paid for research $18,347 5 payments
Xenoscience Organisation paid for research $17,939 4 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.